open access

Vol 80, No 2 (2022)
Original article
Published online: 2021-12-09
Get Citation

Predictors of COVID-19 outcomes in adult congenital heart disease patients — anatomy versus function

Magdalena Lipczyńska1, Ewa Kowalik1, Magdalena Kumor1, Beata Kuśmierczyk-Droszcz1, Anna W Wójcik1, Elżbieta K Biernacka1, Piotr Hoffman1
DOI: 10.33963/KP.a2021.0176
·
Pubmed: 34883525
·
Kardiol Pol 2022;80(2):151-155.
Affiliations
  1. Department of Congenital Heart Disease, National Institute of Cardiology, Warszawa, Poland

open access

Vol 80, No 2 (2022)
Original article
Published online: 2021-12-09

Abstract

Background: It is unclear whether patients with adult congenital heart disease (ACHD) should be considered as an increased risk population with poor outcomes when suffering from COVID-19.
Aims: This study aimed to collect clinical outcome data and to identify risk factors of a complicated course of COVID-19  among ACHD patients.
Methods: Among all outpatients who came to medical attention via telemedicine or direct physician contact at our institution between September 1, 2020 and March 31, 2021, we included all with a COVID-19 diagnosis. The incidence of COVID-19, a clinical course of the disease, and outcome were determined.
Results: One hundred and four (8.7%) out of 1 197 patients who were seen at our outpatient clinic for ACHD patients met the definition of COVID-19. Most of them reported a mild course of COVID-19 (99 [95.5%]). Five patients (4.5%) experienced severe symptoms and needed hospitalization. Two patients (1.9% of all with a confirmed diagnosis, 40% with severe infection) died. In the multivariable analysis, decreased systemic ventricular systolic function and any significant valve stenosis were predictors of a complicated disease course.
Conclusions: Our study confirmed previous results showing that a physiology-based model, rather than an anatomy-based model, better predicted COVID-19 outcomes among ACHD patients, which is of importance for patients and healthcare providers during the COVID-19 pandemic.

Abstract

Background: It is unclear whether patients with adult congenital heart disease (ACHD) should be considered as an increased risk population with poor outcomes when suffering from COVID-19.
Aims: This study aimed to collect clinical outcome data and to identify risk factors of a complicated course of COVID-19  among ACHD patients.
Methods: Among all outpatients who came to medical attention via telemedicine or direct physician contact at our institution between September 1, 2020 and March 31, 2021, we included all with a COVID-19 diagnosis. The incidence of COVID-19, a clinical course of the disease, and outcome were determined.
Results: One hundred and four (8.7%) out of 1 197 patients who were seen at our outpatient clinic for ACHD patients met the definition of COVID-19. Most of them reported a mild course of COVID-19 (99 [95.5%]). Five patients (4.5%) experienced severe symptoms and needed hospitalization. Two patients (1.9% of all with a confirmed diagnosis, 40% with severe infection) died. In the multivariable analysis, decreased systemic ventricular systolic function and any significant valve stenosis were predictors of a complicated disease course.
Conclusions: Our study confirmed previous results showing that a physiology-based model, rather than an anatomy-based model, better predicted COVID-19 outcomes among ACHD patients, which is of importance for patients and healthcare providers during the COVID-19 pandemic.

Get Citation

Keywords

COVID-19 infection, adult congenital heart disease, outcome

About this article
Title

Predictors of COVID-19 outcomes in adult congenital heart disease patients — anatomy versus function

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 80, No 2 (2022)

Article type

Original article

Pages

151-155

Published online

2021-12-09

Page views

769

Article views/downloads

224

DOI

10.33963/KP.a2021.0176

Pubmed

34883525

Bibliographic record

Kardiol Pol 2022;80(2):151-155.

Keywords

COVID-19 infection
adult congenital heart disease
outcome

Authors

Magdalena Lipczyńska
Ewa Kowalik
Magdalena Kumor
Beata Kuśmierczyk-Droszcz
Anna W Wójcik
Elżbieta K Biernacka
Piotr Hoffman

References (12)
  1. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020; 141(23): 1930–1936.
  2. Diller GP, Gatzoulis MA, Broberg CS, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2021; 42(19): 1858–1865.
  3. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 73(12): e81–e8e192.
  4. Schwerzmann M, Ruperti-Repilado FJ, Baumgartner H, et al. Clinical outcome of COVID-19 in patients with adult congenital heart disease. Heart. 2021 [Epub ahead of print].
  5. Lewis MJ, Anderson BR, Fremed M, et al. Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City. J Am Heart Assoc. 2020; 9(23): e017580.
  6. Baumgartner H, De Backer J, Baumgartner H, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42(6): 563–645.
  7. Broberg CS, Kovacs AH, Sadeghi S, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2021; 42(19): 1858–1865.
  8. Ruperti-Repilado FJ, Tobler D, Greutmann M, et al. Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts. Open Heart. 2021; 8(1).
  9. Abbasi J. Large meta-analysis digs into obesity's COVID-19 risks. JAMA. 2020; 324(17): 1709–1711.
  10. Pawlak A, Dreżewski K, Szymański P, et al. Cardiovascular disease, therapy, and mortality of oligosymptomatic and symptomatic patients infected with SARS-CoV-2: experiences of a designated hospital in Poland. Kardiol Pol. 2020; 78(11): 1162–1165.
  11. Fusco F, Scognamiglio G, Merola A, et al. Coronavirus disease 2019 in patients with Fontan circulation. IJC Congenital Heart Disease. 2021; 3: 100126.
  12. Scognamiglio G, Fusco F, Merola A, et al. Caring for adults with CHD in the era of coronavirus disease 2019 pandemic: early experience in an Italian tertiary centre. Cardiol Young. 2020; 30(10): 1405–1408.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl